Ankylosing Spondylitis
📧 Sign up to get email alerts when something new happens for Ankylosing Spondylitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System
This is a study protocol for a cohort study integrating traditional Chinese medicine with Western therapy to evaluate ankylosing spondylitis…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: CALLY Index and Disease Activity in Ankylosing Spondylitis
This clinical trial update indicates the study evaluating the CALLY Index for monitoring disease activity in Ankylosing Spondylitis has comp…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS) [Phase 4]
A Phase 4 clinical trial (COMARIS) studied whether combining methotrexate with adalimumab affects immunization in patients with ankylosing s…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Impact of Low Back Pain Phenotypes on Function and Quality of Life in Ankylosing Spondylitis
This clinical trial update reports that the study evaluating how low back pain phenotypes affect function and quality of life in people with…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: TNFAIP3 Gene Expression in Ankylosing Spondylitis and Psoriatic Arthritis Patients and Its Relation to Disease Activity [NA]
A clinical trial update examining TNFAIP3 gene expression in patients with ankylosing spondylitis and psoriatic arthritis and its relationsh…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Effectiveness of Telerehabilitation in Ankylosing Spondylitis [NA]
A recruiting clinical trial at Inonu University is evaluating the effectiveness of telerehabilitation for ankylosing spondylitis.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps
A safety study of Remsima SC for rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and psoriasis remains active but not rec…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Recombinant Anti-human IL-17A/F Humanized Monoclonal Antibody Injection in the Treatment of Moderate-to-Severe Active AS [Phase 3]
A Phase 3 trial of a recombinant anti-human IL-17A/F monoclonal antibody for moderate-to-severe active ankylosing spondylitis has completed.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Korean Post-marketing Surveillance for Xeljanz XR
Korean post-marketing surveillance study for Xeljanz XR (tofacitinib extended-release) is currently recruiting to monitor safety and effecti…
-
EMA approval · 2026-03-19EMA Authorised: Libmyris (adalimumab) — Stada Arzneimittel AG
EMA authorised Libmyris (adalimumab) by Stada Arzneimittel AG for multiple inflammatory diseases, expanding treatment options in rheumatoid …
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: A Phase III Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis [Phase 3]
A Phase III clinical trial evaluating the efficacy and safety of AK111 in active ankylosing spondylitis has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.
Clinical trial update evaluating injection site pain and adherence when switching from a low to high concentration AVT-02 (adalimumab) acros…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Deep Breathing Combined With Core Stability Exercises in the Treatment of Patients With Ankylosing Spondylitis [NA]
This clinical trial update shows a recruiting study evaluating deep breathing plus core stability exercises for patients with Ankylosing Spo…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Association of Erectile Dysfunction With Neuropathic Pain, Disease Activity, and Functional Status in Male Patients With Axial Spondyloarthritis: A Cross-Sectional Observational Study
This completed cross-sectional observational study investigates the relationship between erectile dysfunction and neuropathic pain, disease …
-
EMA approval · 2026-03-05EMA Authorised: Simponi (golimumab) — Janssen Cilag International NV
The European Medicines Agency authorised Simponi (golimumab) for multiple inflammatory conditions including rheumatoid arthritis, psoriatic …
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Patient-Reported Sleep vs Objective Sleep and Physical Activity Measures in Ankylosing Spondylitis: A Pre-Post Study
A completed pre-post clinical trial evaluating how patients with Ankylosing Spondylitis report sleep quality compared with objective sleep m…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Wet Cupping Therapy in Ankylosing Spondylitis [NA]
A completed clinical trial update on wet cupping therapy for ankylosing spondylitis.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea.
Real-world study assessing the effectiveness of secukinumab in biologic-naïve ankylosing spondylitis patients in Korea; recruitment is ongoi…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Comparison of Cervical Extensor Muscle Thickness, Fat Infiltration, and Cervical Alignment in Patients With Ankylosing Spondylitis With a Healthy Population: a Retrospective Controlled Study
This retrospective controlled study compares cervical extensor muscle thickness, fat infiltration, and cervical alignment between patients w…
-
EMA approval · 2026-02-19EMA Authorised: Hulio (adalimumab) — Biosimilar Collaborations Ireland Limited
The EMA authorised Hulio, a biosimilar of adalimumab, for multiple inflammatory indications including hidradenitis suppurativa, psoriasis, u…
-
EMA approval · 2026-02-17EMA Authorised: Inflectra (infliximab) — Pfizer Europe MA EEIG
EMA authorised Inflectra (infliximab) as a biosimilar to Remicade for multiple inflammatory diseases including rheumatoid and psoriatic arth…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Study to Assess Change in Disease Activity and Adverse Events of RINVOQ in Adult Participants With Ankylosing Spondylitis in the Real-World Japan
A completed real-world study evaluating change in disease activity and adverse events for Rinvoq (tofacitinib) in adults with ankylosing spo…
-
EMA approval · 2026-02-16EMA Authorised: Hefiya (adalimumab) — Sandoz GmbH
EMA authorised Hefiya, a biosimilar adalimumab from Sandoz GmbH, for multiple inflammatory conditions including ankylosing spondylitis, hidr…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Rheumatology Patient Registry and Biorepository
This Clinical Trial Update describes a Yale University-led rheumatology patient registry and biorepository that is currently recruiting to c…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis
A completed clinical trial evaluating adverse events and changes in disease symptoms in Korean participants with rheumatoid arthritis, atopi…